Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy recommendation.
Analyst Price Forecast Suggests 35.56% Upside
As of December 23, 2024, the average one-year price target for Orthofix Medical is $24.89/share. The forecasts range from a low of $22.22 to a high of $28.56. The average price target represents an increase of 35.56% from its latest reported closing price of $18.36 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Orthofix Medical is 515MM, a decrease of 34.29%. The projected annual non-GAAP EPS is 1.73.
What is the Fund Sentiment?
There are 317 funds or institutions reporting positions in Orthofix Medical. This is an increase of 14 owner(s) or 4.62% in the last quarter. Average portfolio weight of all funds dedicated to OFIX is 0.19%, an increase of 15.73%. Total shares owned by institutions increased in the last three months by 1.39% to 39,057K shares. 
The put/call ratio of OFIX is 0.53, indicating a bullish outlook.
What are Other Shareholders Doing?
Armistice Capital holds 3,768K shares representing 9.86% ownership of the company. In its prior filing, the firm reported owning 3,750K shares , representing an increase of 0.48%. The firm increased its portfolio allocation in OFIX by 49.44% over the last quarter.
Rubric Capital Management holds 3,695K shares representing 9.67% ownership of the company. No change in the last quarter.
Engine Capital Management holds 3,369K shares representing 8.82% ownership of the company. No change in the last quarter.
Paradigm Capital Management holds 2,556K shares representing 6.69% ownership of the company. In its prior filing, the firm reported owning 2,556K shares , representing an increase of 0.02%. The firm decreased its portfolio allocation in OFIX by 33.90% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 1,123K shares representing 2.94% ownership of the company. No change in the last quarter.
Orthofix Medical Background Information
(This description is provided by the company.)
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with health care professionals to improve patients' lives. Headquartered in Lewisville, Texas, Orthofix's spine and orthopedic extremities products are distributed in more than 70 countries via the Company's sales representatives and distributors.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
